Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy

MLA

Ren-Yu Zhang, et al. “Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy.” Frontiers in Cell and Developmental Biology, vol. 7, Oct. 2019. EBSCOhost, https://doi.org/10.3389/fcell.2019.00233.

APA

Ren-Yu Zhang, Ding Wei, Ze-Kun Liu, Yu-Le Yong, Wei Wei, Zhi-Yun Zhang, Jian-Jun Lv, Zhao Zhang, Zhi-Nan Chen, & Huijie Bian. (2019). Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy. Frontiers in Cell and Developmental Biology, 7. https://doi.org/10.3389/fcell.2019.00233

Chicago

Ren-Yu Zhang, Ding Wei, Ze-Kun Liu, Yu-Le Yong, Wei Wei, Zhi-Yun Zhang, Jian-Jun Lv, Zhao Zhang, Zhi-Nan Chen, and Huijie Bian. 2019. “Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy.” Frontiers in Cell and Developmental Biology 7 (October). doi:10.3389/fcell.2019.00233.